Drugs / Caroverin
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT01174979 | Jan 2011 → Aug 2015 | tinnitus | Phafag AG | Suspended | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Caroverin | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01174979 ↗ |
| Route | Other | “transtympanic treatment” NCT01174979 ↗ |